Healthcare Distribution Alliance – Patients Move Us.
Share Print


HDA Statement on COVID-19 Vaccine Distribution

August 14, 2020

ARLINGTON, Va. — Healthcare Distribution Alliance (HDA) President and CEO Chester "Chip" Davis, Jr., released the following statement regarding the distribution of COVID-19 vaccines and supplies through Operation Warp Speed.

"HDA applauds the federal government’s decision to leverage the logistics expertise of our members to ensure that COVID-19 vaccines, once approved, will be distributed safely and efficiently to point-of-care sites across the country. Today’s announcement strongly reaffirms the importance of public-private collaboration and the critical role it has played, and will continue to do so, in our nation’s response to the COVID-19 pandemic.” 

Additional Information:


The Healthcare Distribution Alliance (HDA) represents primary pharmaceutical distributors — the vital link between the nation’s pharmaceutical manufacturers and pharmacies, hospitals, long-term care facilities, clinics and others nationwide. Since 1876, HDA has helped members navigate regulations and innovations to get the right medicines to the right patients at the right time, safely and efficiently. The HDA Research Foundation, HDA’s nonprofit charitable foundation, serves the healthcare industry by providing research and education focused on priority healthcare supply chain issues.


© 2020 Healthcare Distribution Alliance. All rights reserved.
HDA: E | C | C2 | NF | O365